Phase 1 study of biweekly (Q2W) anti-EGFR monoclonal antibody (mAb) mixture Sym004 in patients (pts) with metastatic colorectal cancer (mCRC) resistant to previous anti-EGFR treatment

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 32; no. 15_suppl; p. 3551
Main Authors Argilés, Guillem, Dienstmann, Rodrigo, Benavent Viñuales, Marta, Cervantes, Andres, Rosello Keranen, Susana, H. Hansen, Ulla, Skartved, Niels Jorgen Ostergaard, Horak, Ivan David, Braun, Stephan, Garcia Carbonero, Rocio
Format Journal Article
LanguageEnglish
Published 20.05.2014
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2014.32.15_suppl.3551